{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieovjla5e6kyrs4lhsqni626rl2a2vy22ffwvdvqdrfunfninkkqu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mko3oxob2zo2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicoztzzzq7lrng4pa2kj5mkicxd42twaft6nqn4ce3pxflm7nzvhq"
    },
    "mimeType": "image/jpeg",
    "size": 104611
  },
  "path": "/news/2026-04-anti-inflammatory-drug-potential-blood.html",
  "publishedAt": "2026-04-29T17:20:06.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at Dresden University Hospital may have discovered a new therapeutic approach for treating myelodysplastic syndromes (MDS). In a recent study, the team headed by Prof. Manja Wobus and Dr. Katja Sockel demonstrated that the anti-inflammatory drug tasquinimod improves blood formation—which is impaired in MDS—and reduces bone damage in preclinical models.",
  "title": "Anti-inflammatory drug shows potential for improved blood formation and treatment of bone damage"
}